◼ Archived
Business
New belly fat injection cuts dangerous fat surrounding organs by 12% in early human trial
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Phase 3
8 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
Lilly sets up next-gen obesity battle with full phase 3 retatrutide data
Lilly positions its retatrutide drug combo for a next-generation obesity battle following full phase 3 study results.
◼ Archived
Business
Amgen’s Horizon-acquired fusion protein eases Sjögren's severity in ph. 3 win
Amgen announces positive topline Phase 3 results for dazodalibep in moderate-to-severe systemic Sjögren's disease.
◼ Archived
Business
🔮 fades ✗
Novartis Stock Tanks Following Third Major Pipeline Setback
Novartis stock experiences a sharp decline following a Phase 3 failure for a dystrophy drug linked to its $12 billion Avidity acquisition.
◼ Archived
Business
🔮 fades ✓
Summit Packs A Punch For Merck's Keytruda
Summit Therapeutics and Akeso report that their cancer drug ivonescimab has met overall survival goals in a Phase 3 lung cancer trial.
◼ Archived
Business
🔮 fades ✗
GSK catches phase 3 fever after mRNA flu vaccine beats standard shots
GSK advances its mRNA flu vaccine candidate to phase 3 trials following successful mid-stage performance data.
◼ Archived
Business
🔮 fades
Eli Lilly Preparing Retatrutide Applications After Positive Weight-Loss Data
Eli Lilly is moving toward 2027 regulatory filings for retatrutide after successful Phase 3 obesity trials showing significant weight and A1C improvements.
◼ Archived
Business
🔮 fades
Why Arrowhead Shot Sky-High, While Chief Rival Ionis Toppled
Arrowhead stock surges to multi-year highs following a major Phase 3 trial success, while chief rival Ionis falls.